Utilization of Extracorporeal Membrane Oxygenation Alleviates Intestinal Ischemia-reperfusion Injury in Prolonged Hemorrhagic Shock Animal Model
Overview
Biophysics
Cell Biology
Affiliations
Intestinal ischemia-reperfusion injury is one of the main factors leading to multiple organ failure after resuscitation of prolonged hemorrhagic shock; however, the current conventional fluid resuscitation still cannot effectively reduce intestinal injury caused by prolonged hemorrhagic shock. To investigate the effect of ECMO resuscitation on alleviating intestinal ischemia-reperfusion injury in a prolonged hemorrhagic shock rabbit model. Thirty New Zealand white rabbits were randomly divided into three groups: control group, conventional fluid resuscitation group, and ECMO resuscitation group. The prolonged hemorrhagic shock model was established by keeping the arterial blood pressure from 31 to 40 mmHg for 3 h through the femoral artery bleeding, and performing the resuscitation for 2 h by conventional fluid resuscitation and ECMO resuscitation, respectively. Chiu's score of intestinal injury, serum lactate and TNF-α levels, intestinal mucosamyeloperoxidase (MPO) activity, intercellular adhesion molecule (ICAM-1), and Claudin-1expression were detected. The mean arterial blood pressure in Group 2 was significantly higher after resuscitation than in Group 1, but serum lactate and inflammatory cytokines TNF-α level were significantly lower. And Chiu's score of intestinal injury and myeloperoxidase (MPO) activity level and ICAM-1 expression were significantly lower in the ECMO resuscitation group, in which the Claudin-1 levels were significantly increased. ECMO resuscitation for the prolonged hemorrhagic shock improves tissue perfusion and reduces the systemic inflammation, and thus alleviates intestinal damage caused by prolonged hemorrhagic shock.
Exploring the Impact of Extracorporeal Membrane Oxygenation on the Endothelium: A Systematic Review.
Li Y, Volleman C, Dubelaar D, Vlaar A, van den Brom C Int J Mol Sci. 2024; 25(19).
PMID: 39409009 PMC: 11477268. DOI: 10.3390/ijms251910680.
Gan Y, Tian X, Yao H, Huo F, Feng Y Transfus Med Hemother. 2024; 51(3):164-174.
PMID: 38867809 PMC: 11166905. DOI: 10.1159/000527934.
Wang R, Pan T, Huang L, Liao C, Li Q, Jiang H Quant Imaging Med Surg. 2021; 11(7):2968-2979.
PMID: 34249627 PMC: 8250019. DOI: 10.21037/qims-20-1160.
Almoiliqy M, Wen J, Qaed E, Sun Y, Lian M, Mousa H Oxid Med Cell Longev. 2020; 2020:4196548.
PMID: 33381264 PMC: 7748914. DOI: 10.1155/2020/4196548.
Jacquot A, Lepage X, Merckle L, Girerd N, Levy B BMJ Open. 2019; 9(10):e031697.
PMID: 31615800 PMC: 6797322. DOI: 10.1136/bmjopen-2019-031697.